Palmar Hyperhidrosis Treatment Market Report 2026

Palmar Hyperhidrosis Treatment Market Overview

• Palmar Hyperhidrosis Treatment market size has reached to $0.97 billion in 2025 • Expected to grow to $1.38 billion in 2030 at a compound annual growth rate (CAGR) of 7.2% • Growth Driver: Rising Prevalence Of Palmar Hyperhidrosis Fueling The Growth Of The Market Due To Increasing Stress Levels And Improved Condition Awareness • Market Trend: Advances In At-Home Therapies For Excessive Perspiration • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Palmar Hyperhidrosis Treatment Market?

Palmar hyperhidrosis treatment refers to a range of medical interventions designed to manage excessive sweating of the palms, a condition caused by overactive sweat glands. This condition can significantly impact daily activities, social interactions, and emotional well-being. The main purpose of this treatment is to reduce sweat production, improve hand dryness, and enhance the patient's quality of life. The main treatment types of palmar hyperhidrosis treatment are topical treatments, oral medications, botulinum toxin injections, iontophoresis, surgical interventions, and others. Topical treatments involve the application of medications directly to the skin, such as antiperspirants containing aluminum chloride. Palmar hyperhidrosis occurs in various age groups, including children, adolescents, adults, and the elderly, and is categorized based on severity as mild, moderate, or severe. The key end users of these treatments include hospitals, dermatology clinics, specialty clinics, and homecare settings.

What Is The Palmar Hyperhidrosis Treatment Market Growth Forecast?

The palmar hyperhidrosis treatment market size is expected to see strong growth in the next few years. It will grow to $1.38 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing demand for long-term treatment solutions, rising adoption of homecare-based therapies, growth in patient-centric dermatology care, ongoing clinical research into novel therapies, expanding access to advanced dermatological treatments. Major trends in the forecast period include increasing adoption of non-invasive treatment options, rising demand for home-use iontophoresis devices, growing use of botulinum toxin therapies, expansion of personalized treatment approaches, enhanced focus on patient quality of life.

Global Palmar Hyperhidrosis Treatment Market Segmentation

1) By Treatment Type: Topical Treatments, Oral Medications, Botulinum Toxin Injections, Iontophoresis, Surgical Interventions, Other Treatment Types 2) By Patient Age Group: Children, Adolescents, Adults, Elderly 3) By Severity Of Hyperhidrosis: Mild, Moderate, Severe 4) By End-User: Hospitals, Dermatology Clinics, Specialty Clinics, Homecare Subsegments: 1) By Topical Treatments: Aluminum Chloride-Based Antiperspirants, Natural Or Herbal Formulations, Glycopyrronium-Based Creams Or Wipes 2) By Oral Medications: Anticholinergics, Benzodiazepines, Beta-Blockers 3) By Botulinum Toxin Injections: Botulinum Toxin Type A, Liposomal Botulinum Formulations, Botulinum Toxin Type B 4) By Iontophoresis: Tap Water Iontophoresis, Portable Or Home-Use Iontophoresis Devices, Iontophoresis With Anticholinergic Agents 5) By Surgical Interventions: Endoscopic Thoracic Sympathectomy (Ets), Microscopic Sympathectomy, Sympathectomy By Radiofrequency Ablation 6) By Other Treatment Types: Laser Therapy, Nerve-Blocking Agents Or Injections, Microwave Therapy

What Are The Drivers Of The Palmar Hyperhidrosis Treatment Market?

The rising prevalence of palmar hyperhidrosis is expected to propel the growth of the palmar hyperhidrosis treatment market going forward. Palmar hyperhidrosis is a condition characterized by excessive, uncontrollable sweating of the palms, often due to overactive nerves without an underlying medical cause. The rise in palmar hyperhidrosis cases is largely driven by increasing stress and anxiety levels, which overstimulate the sympathetic nervous system and lead to excessive sweating. Palmar hyperhidrosis treatments help manage palmar hyperhidrosis by reducing excessive hand sweating, making them ideal for individuals facing challenges in daily activities. They enhance comfort and confidence by minimizing moisture-related discomfort, improving personal and professional interactions. For instance, in January 2023, according to the National Library of Medicine, a US-based medical research department, hyperhidrosis (HH) remains an under-recognized and under-researched chronic condition, and its prevalence is estimated at 1.6% in the UK and between 1.0% and 4.8% in the USA. Therefore, the rising prevalence of palmar hyperhidrosis is driving the growth of the palmar hyperhidrosis treatment industry. The increasing healthcare expenditure is expected to propel the growth of the palmar hyperhidrosis treatment market going forward. Healthcare expenditure refers to the total amount of money spent on medical services, treatments, facilities, research, and public health initiatives to maintain or improve health outcomes. The increasing demand for healthcare expenditure is due to the aging population, which requires more medical care, treatments, and long-term healthcare services. Rising healthcare expenditure supports palmar hyperhidrosis treatment by improving access to advanced therapies and diagnostic services. It enables the affordability of specialized options like botulinum toxin injections, enhancing treatment effectiveness and patient outcomes. For instance, in December 2024, according to the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, the national health expenditures (NHE) grew by 7.5% to $4.9 trillion in 2023, accounting for 17.6% of gross domestic product (GDP). Additionally, between 2023 and 2032, average national health expenditures (NHE) are projected to grow at an average annual rate of 5.6%, resulting in an increase in the health spending share of gross domestic product (GDP) from 17.3% in 2022 to 19.7% in 2032. Therefore, the increasing healthcare expenditure is driving the growth of the palmar hyperhidrosis treatment industry.

Key Players In The Global Palmar Hyperhidrosis Treatment Market

Major companies operating in the palmar hyperhidrosis treatment market are AbbVie Inc, GlaxoSmithKline plc, Eli Lilly and Company, Dr August Wolff GmbH And Co KG, Merz Pharma GmbH And Co KGaA, Kaken Pharmaceutical Co Ltd, Medytox Inc, Revance Therapeutics Inc, Alma Lasers Ltd, Journey Medical Corporation, Fotona doo, Candela Corporation, Brickell Biotech Inc, Avanor Healthcare Ltd, C Cube Advanced Technologies, Dermadry Laboratories Inc, TheraVida Inc, ThermiGen LLC, Ulthera Inc, Cutera Inc, Lumenis Ltd, Medtronic plc

Global Palmar Hyperhidrosis Treatment Market Trends and Insights

Major companies operating in the palmar hyperhidrosis treatment market are focusing on developing innovative solutions such as topical transdermal anticholinergic formulations to provide non-invasive, home-friendly treatments and reduce systemic side effects compared with oral therapies. Topical transdermal anticholinergic lotions involve delivering an antimuscarinic agent locally across the skin to target eccrine sweat glands, which helps manage palmar hyperhidrosis by reducing sweat production, improving convenience with at-home application, and enabling repeated use compared with injections or energy-based procedures. For instance, in May 2023, Hisamitsu Pharmaceutical Co., Ltd., a Japan-based pharmaceutical company, launched APOHIDE Lotion 20%, an innovative topical treatment for palmar hyperhidrosis. This lotion contains 20% oxybutynin hydrochloride formulated using Hisamitsu’s transdermal drug delivery technology. It functions by locally inhibiting acetylcholine-mediated sweat gland activity, while its transdermal formulation aims to limit systemic exposure compared with oral oxybutynin, offering a safer and more convenient alternative for patients.

Regional Outlook

North America was the largest region in the palmar hyperhidrosis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Palmar Hyperhidrosis Treatment Market?

The palmar hyperhidrosis treatment market consists of revenues earned by entities by providing services such as diagnosis and assessment services, customized treatment planning, and psychological counseling and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The palmar hyperhidrosis treatment market also includes sales of clinical-strength antiperspirant wipes, microwave thermolysis devices, and topical anticholinergic creams or gels. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Palmar Hyperhidrosis Treatment Market Report 2026?

The palmar hyperhidrosis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the palmar hyperhidrosis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.